NOMURA HOLDINGS INC-SPON ADR (NMR)
US65535H2085 - ADR
NMR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 219 industry peers in the Capital Markets industry. NMR may be in some trouble as it scores bad on both profitability and health. NMR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
NMR had positive earnings in the past year.
NMR had a positive operating cash flow in the past year.
Each year in the past 5 years NMR has been profitable.
In multiple years NMR reported negative operating cash flow during the last 5 years.
1.2 Ratios
NMR has a worse Return On Assets (0.30%) than 76.74% of its industry peers.
NMR has a worse Return On Equity (4.95%) than 67.44% of its industry peers.
The Return On Invested Capital of NMR (0.35%) is worse than 79.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NMR is significantly below the industry average of 17.77%.
The last Return On Invested Capital (0.35%) for NMR is above the 3 year average (0.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.3% | ||
| ROE | 4.95% | ||
| ROIC | 0.35% |
ROA(3y)0.27%
ROA(5y)0.34%
ROE(3y)4.27%
ROE(5y)5.33%
ROIC(3y)0.31%
ROIC(5y)0.34%
1.3 Margins
NMR's Profit Margin of 3.99% is on the low side compared to the rest of the industry. NMR is outperformed by 73.95% of its industry peers.
In the last couple of years the Profit Margin of NMR has declined.
NMR has a worse Operating Margin (6.59%) than 78.14% of its industry peers.
In the last couple of years the Operating Margin of NMR has declined.
NMR has a worse Gross Margin (37.57%) than 69.77% of its industry peers.
In the last couple of years the Gross Margin of NMR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | 3.99% | ||
| GM | 37.57% |
OM growth 3Y-22.7%
OM growth 5YN/A
PM growth 3Y-25.03%
PM growth 5YN/A
GM growth 3Y-24.32%
GM growth 5Y-9.19%
2. Health
2.1 Basic Checks
Compared to 1 year ago, NMR has less shares outstanding
The number of shares outstanding for NMR has been reduced compared to 5 years ago.
The debt/assets ratio for NMR is higher compared to a year ago.
2.2 Solvency
NMR has an Altman-Z score of -0.32. This is a bad value and indicates that NMR is not financially healthy and even has some risk of bankruptcy.
NMR has a worse Altman-Z score (-0.32) than 87.91% of its industry peers.
A Debt/Equity ratio of 10.52 is on the high side and indicates that NMR has dependencies on debt financing.
NMR has a worse Debt to Equity ratio (10.52) than 90.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.52 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.32 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.21 indicates that NMR may have some problems paying its short term obligations.
NMR has a Current ratio of 0.21. This is amonst the worse of the industry: NMR underperforms 90.70% of its industry peers.
A Quick Ratio of 0.21 indicates that NMR may have some problems paying its short term obligations.
NMR has a Quick ratio of 0.21. This is amonst the worse of the industry: NMR underperforms 86.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.21 | ||
| Quick Ratio | 0.21 |
3. Growth
3.1 Past
NMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.89%.
The earnings per share for NMR have been decreasing by -13.34% on average. This is quite bad
Looking at the last year, NMR shows a very strong growth in Revenue. The Revenue has grown by 50.90%.
NMR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.75% yearly.
EPS 1Y (TTM)-33.89%
EPS 3Y-23.06%
EPS 5Y-13.34%
EPS Q2Q%153.22%
Revenue 1Y (TTM)50.9%
Revenue growth 3Y8.4%
Revenue growth 5Y4.75%
Sales Q2Q%30.25%
3.2 Future
The Earnings Per Share is expected to grow by 31.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.52% on average over the next years.
EPS Next Y78.95%
EPS Next 2Y65.7%
EPS Next 3Y43.45%
EPS Next 5Y31.84%
Revenue Next Year0.68%
Revenue Next 2Y7.93%
Revenue Next 3Y4.5%
Revenue Next 5Y3.52%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NMR is valuated rather expensively with a Price/Earnings ratio of 24.86.
Based on the Price/Earnings ratio, NMR is valued a bit more expensive than the industry average as 65.12% of the companies are valued more cheaply.
NMR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 31.46.
NMR is valuated reasonably with a Price/Forward Earnings ratio of 8.86.
Based on the Price/Forward Earnings ratio, NMR is valued a bit cheaper than the industry average as 73.49% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.63. NMR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.86 | ||
| Fwd PE | 8.86 |
4.2 Price Multiples
NMR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NMR is cheaper than 61.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 31.57 |
4.3 Compensation for Growth
NMR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NMR's earnings are expected to grow with 43.45% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y65.7%
EPS Next 3Y43.45%
5. Dividend
5.1 Amount
NMR has a Yearly Dividend Yield of 2.60%.
Compared to an average industry Dividend Yield of 8.55, NMR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.18, NMR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
5.2 History
On average, the dividend of NMR grows each year by 7.29%, which is quite nice.
NMR has been paying a dividend for at least 10 years, so it has a reliable track record.
NMR has decreased its dividend recently.
Dividend Growth(5Y)7.29%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
NMR pays out 36.27% of its income as dividend. This is a sustainable payout ratio.
The dividend of NMR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP36.27%
EPS Next 2Y65.7%
EPS Next 3Y43.45%
NOMURA HOLDINGS INC-SPON ADR
NYSE:NMR (10/21/2024, 4:26:20 PM)
After market: 5.22 0 (0%)5.22
-0.12 (-2.25%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap15.42B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.86 | ||
| Fwd PE | 8.86 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.3% | ||
| ROE | 4.95% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 6.59% | ||
| PM (TTM) | 3.99% | ||
| GM | 37.57% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.52 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.21 | ||
| Quick Ratio | 0.21 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-33.89%
EPS 3Y-23.06%
EPS 5Y
EPS Q2Q%
EPS Next Y78.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)50.9%
Revenue growth 3Y8.4%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y